Overview

Company Overview

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology represents a major breakthrough in immune system management - safe and selective “tolerizing” of immune response.  This technology addresses one of the most fundamental challenges in human immunology:  how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats.

Our mission is to revolutionize the fields of transplantation, cancer treatment and reversal of vital organ disease, utilizing our breakthrough immune tolerance and organ regeneration technologies, in order to save lives and fulfill the inspiring promise of immunotherapy.

Stock Information

Symbol CLCS
Market OTCPink:
Market Loading...
Price Loading...
Change Loading...
Volume Loading...